Sun Pharma hits three-month low post Q2 results; drops 10% in three days

The stock was down 5 per cent at Rs 533, trading at its lowest level since July 17, 2018, on BSE.

Shares of Sun Pharmaceutical Industries hit  three-month low of Rs 533, down 5 per cent on  BSE, after the company posted a consolidated loss of Rs 2.18 billion for the quarter-ended September (Q2FY19), on account of a one-time loss of Rs 12.14 billion on Modafinil antitrust litigation.

The stock was trading at its lowest level since July 17, 2018. In past three trading sessions, it has fallen 10 per cent from Rs 596, as compared to a marginal 0.15 per cent rise in the S&P BSE Sensex.

Excluding the exceptional expenses, the net profit stood at Rs 9.96 billion.